Synovial Gene expression after Hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc Fusion Protein

Synovial Gene expression after Hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc Fusion Protein

Saved in:

Bibliographic Details
Main Authors:	Bilgimol Chumappumkal Joseph, Thomas C. Whisenant, Esther J. Cooke, Jenny Y. Zhou, Nicca Falah, Juan Andres De-Pablo Moreno, Annette von Drygalski
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088034/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states
by: Diego Butera, et al.
Published: (2025-08-01)

Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia A
by: Meganathan Kannan PhD, et al.
Published: (2025-03-01)

Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
by: Himani Chand, et al.
Published: (2025-03-01)

Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
by: Marcus Ljungkvist
Published: (2017-11-01)

PO05 | Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study
Published: (2025-08-01)

Prospective, Observational Study of the Clinical Outcomes of FVIII Treatment in Adults and Adolescents with Severe Haemophilia A
by: Pratima Chowdary, et al.
Published: (2025-01-01)

The influence of dead space in blood sampling needle on FVIII level and pharmacokinetic profiles in children with hemophilia
by: Yingzi Zhen, et al.
Published: (2024-12-01)

Corrigendum: Prospective, Observational Study of the Clinical Outcomes of FVIII Treatment in Adults and Adolescents with Severe Haemophilia A
by: Pratima Chowdary, et al.
Published: (2025-01-01)

The effect of prophylactic FVIII infusion combined with personalized rehabilitation on joint health and quality of life in children with hemophilia
by: Yaojin Sun, et al.
Published: (2025-07-01)

Analyzing 6211 unique variants in the upgraded interactive FVIII web database reveals novel insights into hemophilia A
by: Emily H. T. Print, et al.
Published: (2025-08-01)

Rational design of FVIII sialylated peptides to target Siglec-3 and Siglec-9 and improve peptide formulations for reverse vaccines
by: Eleonora Nardini, et al.
Published: (2025-04-01)

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX
by: Enhao Li, et al.
Published: (2025-08-01)

Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study
by: Olga Benítez Hidalgo MD, et al.
Published: (2025-03-01)

Acute obstetric coagulopathy: need for innovation
by: Bilgimol Chumappumkal Joseph, et al.
Published: (2025-06-01)

FVIII peptides presented on HLA-DP and identification of an A3 domain peptide binding with high affinity to the commonly expressed HLA-DP4
by: Mariarosaria Miranda, et al.
Published: (2024-12-01)

Development and validation of an innovative approach to estimating FVIII levels and designing personalised doses in the prophylactic treatment of haemophilia A: based on the principle of the two-compartment model
by: Xuemei Wu, et al.
Published: (2025-07-01)

Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
by: Do-Hun Kim, et al.
Published: (2025-01-01)

BLEEDING RATE, FVIII UTILIZATION, CORTICOSTEROID USE, QUALITY OF LIFE AND SAFETY 4-YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC IN A BRAZILIAN COHORT: RESULTS FROM GENER8-1
by: MC Ozelo, et al.
Published: (2024-10-01)

Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A
by: Vincent P. Diego, et al.
Published: (2025-04-01)

Scurvy as a mimicker of arthritis: Isolated hemarthrosis due to vitamin C deficiency, a case report
by: Rohit Sharma, et al.
Published: (2024-12-01)

The Effect of Resistance Training on Physical Characteristics Hemarthrosis Joints
by: Behrouz Parhampour, et al.
Published: (2015-12-01)

Persistent Hemarthrosis of the Knee after Arthroscopic Meniscal Repair
by: Shunichiro Kambara, et al.
Published: (2023-01-01)

Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis
by: Hanns-Martin Lorenz, et al.
Published: (2024-09-01)

Successful Selective Embolization for Recurrent Hemarthrosis after Knee Arthroplasty
by: Cristian Barrientos, et al.
Published: (2019-01-01)

Differential diagnosis of non-traumatic knee hemarthrosis (case report)
by: A. A. Roskidaylo
Published: (2025-02-01)

A novel HVEM-Fc recombinant protein for lung cancer immunotherapy
by: Yuanshan Yao, et al.
Published: (2025-02-01)

Recurrent Hemarthrosis following Resections of Benign Bone Tumors: A Case Report of Two Pediatric Cases
by: Ryan H. Barnes, et al.
Published: (2021-01-01)

Radiosynovectomy is a safe and an efficient alternative in the treatment of chronic, recurrent knee hemarthrosis
by: Ioannis Iakovou, et al.
Published: (2020-04-01)

Utilizing artificial intelligence for the detection of hemarthrosis in hemophilia using point-of-care ultrasonography
by: Pascal N. Tyrrell, et al.
Published: (2024-11-01)

An Unusual Presentation of Delayed Hemarthrosis Following Total Knee Arthroplasty: A Case Report
by: Rudra Prabhu, et al.
Published: (2025-08-01)

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space
by: Michael E. Cloesmeijer, et al.
Published: (2024-10-01)

Purification of a Fc-Fusion Protein with [Bathophenathroline:metal] Complexes
by: Thisara Jayawickrama Withanage, et al.
Published: (2025-01-01)

Fc Proteoforms of ACPA IgG Discriminate Autoimmune Responses in Plasma and Synovial Fluid of Rheumatoid Arthritis Patients and Associate with Disease Activity
by: Constantin Blöchl, et al.
Published: (2025-04-01)

Applying Fc-fusion proteins to tolerize perinatally and block inhibitor formation
by: David W. Scott
Published: (2025-07-01)

Treating recurrent hemarthrosis after knee arthroplasty with selective embolization: a cohort study of 56 patients
by: Suvi-Maria Sirola, et al.
Published: (2025-01-01)

A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A
by: Johannes Oldenburg, et al.
Published: (2025-12-01)

Double Proteolysis for N- and O-glycan Analysis of Fc-fusion Protein Etanercept
by: V. G. Varzieva, et al.
Published: (2023-02-01)

The neonatal Fc receptor in cancer FcRn in cancer
by: Diana Cadena Castaneda, et al.
Published: (2020-07-01)

Optimization of the Fc-fusion protein refolding method produced from the bacterial expression system
by: P. S. Astrelina, et al.
Published: (2025-03-01)

Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults ≥50 years of age: a randomised, active-controlled, non-inferiority trial
by: Peng-Fei Jin, et al.
Published: (2025-08-01)